Register
Login:
Share:
Email Facebook Twitter

AVCT Share Chat - RSS Feed

Avacta Share Chat (AVCT)



Share Price: 0.83Bid: 0.82Ask: 0.84Change: 0.00 (0.00%)No Movement on Avacta
Spread: 0.02Spread as %: 2.44%Open: 0.83High: 0.83Low: 0.83Yesterday’s Close: 0.83


Share Discussion for Avacta (AVCT)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


clogheen
Posts: 1,395
Observation
Opinion:No Opinion
Price:1.09
Broker TP 1.71p
28 Nov '13
26 Sep 13

Avacta Group PLC

Numis

Buy

1.09

1.40

1.70

Reiterates
 
cipro
Posts: 753
Observation
Opinion:No Opinion
Price:1.09
IN NOW
28 Nov '13
I held back because I was informed Jan 14 could good entry point should have got in at .92 last month still this sp can only go one way now lol
clogheen
Posts: 1,395
Observation
Opinion:No Opinion
Price:1.09
AVCT
28 Nov '13
The USA is a huge market,,,,,,,,,,,,,and IMV could see the SP move north pdq,,,,,,,,,DYOR of course as no advice intended

http://www.cambridgenetwork.co.uk/news/avacta-customers-to-benefit-from-new-applications-support-fo7085/
byebyebye
Posts: 66
Off Topic
Opinion:Buy
Price:1.08
On the up
28 Nov '13
Been in 3 years, good to see a sustained increase in sp,
Onwards and upwards in 2014,
clogheen
Posts: 1,395
Observation
Opinion:No Opinion
Price:1.04
AVCT
28 Nov '13
All positive news for AVCT,,,,,,,,,,,hope all of you got in or topped up on the low's...........interesting times ahead IMV,,,,,,,DYOR
Wisheyedbortum
Posts: 440
Observation
Opinion:No Opinion
Price:1.04
sukithedog
28 Nov '13
Thanks for the info, it certainly is good news and it's good to see the sp break through the 1p barrier. After all this time it would be very welcome to see a gradual tick up.
sukithedog
Posts: 276
Off Topic
Opinion:Strong Buy
Price:0.94
news - good
27 Nov '13
New Canine Lymphoma Blood Test Launched
Wed, 27th Nov 2013 10:01
RNS Number : 0531U
Avacta Group PLC
27 November 2013

?

27 November 2013

Avacta Group plc

("Avacta" or the "Group")

New canine lymphoma blood test launched

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare announced at the recent London Vet Show that its new canine lymphoma blood test was now available to veterinary practices in the UK.

Lymphoma is one of the most common malignancies to affect dogs, accounting for approximately 20% of all canine tumours. It can be seen in any breed of dog with some breeds showing particularly high incidence, including Golden Retrievers, Boxers, German Shepherds and Terriers.

Avacta has completed the development of the new canine lymphoma blood test (cLBT) which is now being provided to vets through reference laboratory services in the UK under Avacta's SensiTest® brand. Avacta is now seeking commercial partners in global markets who will be supplied with testing kits and in due course the cLBT will also be offered on the in-clinic Sensipod testing platform.

The cLBT enables detection of lymphoma up to eight weeks prior to physical symptoms (swollen lymph nodes) becoming easily detectable by palpation. This simple blood test is more objective and sensitive than palpation, is able to differentiate clearly between benign and malignant lymphadenopathy, and is aimed at allowing veterinarians to diagnose and treat lymphoma patients earlier in the disease progression which should lead to better outcomes. The cLBT has also been shown in clinical trials to be effective in remission monitoring if used monthly following chemotherapy.

The cLBT is a simple procedure that requires serum from 2ml of whole blood. The test measures the level of c-reactive protein and haptoglobin using Avacta's proprietary tests, then combines the results with a unique and proprietary algorithm to provide accurate results to assist in the diagnosis of lymphoma that could not be achieved with the measurement of a single biomarker alone.

Alastair Smith, CEO of Avacta Commented: "The London Vet Show 2013 brings together more veterinary professionals and exhibitors than any other event in the UK, making it the perfect platform for Avacta Animal Health to launch its latest innovation - the canine lymphoma blood test. This is the first of many new tests that will be made available to vets through our reference laboratory and test kits, and on our in-clinic analyser Sensipod® in the next year or so. I am particularly pleased that this approach of using multiple biomarkers that are combined with a multivariate algorithm, is proving to be a powerful generic approach which we are applying to other high value testing opportunities with good results."
cipro
Posts: 753
Off Topic
Opinion:No Opinion
Price:0.93
Wish
19 Nov '13
Fnx again I will bare that in mind when funds available couple of weeks time so sub 1p would be good entry point
Wisheyedbortum
Posts: 440
Answer
Opinion:No Opinion
Price:0.94
cipro.
19 Nov '13
No rush, but early 2014 you should consider making a move while the price is this low.
cipro
Posts: 753
Off Topic
Opinion:No Opinion
Price:0.94
Wish
18 Nov '13
Fnx I will keep on watch list not yet brought in



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.